Provention Bio stock rockets ~260% on ~$2.9B acquisition by Sanofi (PRVB)
Maks_Lab Sanofi (NASDAQ:SNY) is acquiring Red Bank, N.J.- based diabetes drugmaker Provention Bio (NASDAQ:PRVB) for ~$2.9B. Under the agreement, Sanofi ...
Maks_Lab Sanofi (NASDAQ:SNY) is acquiring Red Bank, N.J.- based diabetes drugmaker Provention Bio (NASDAQ:PRVB) for ~$2.9B. Under the agreement, Sanofi ...
HJBC/iStock Editorial through Getty Photographs Qatar's state-owned oil and fuel producer mentioned Sunday it signed a partnership cope with TotalEnergies ...
Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.